Inhibition of norepinephrine-, angiotensin II-, and vasopressin-induced contractions of smooth muscle by acyl derivatives of adenosine-3',5'-monophosphate.
D000215:Acylation; D000227:Adenine Nucleotides / Q000494:pharmacology*; D000249:Adenosine Monophosphate / Q000494:pharmacology; D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D000818:Animals; D001011:Aorta / Q000187:drug effects; D002087:Butyrates / Q000494:pharmacology; D004336:Drug Antagonism; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors*; D051381:Rats; D014631:Valerates / Q000494:pharmacology; D014649:Vas Deferens / Q000187:drug effects; D014667:Vasopressins / Q000037:antagonists & inhibitors*
D000227:Adenine Nucleotides; D002087:Butyrates; D014631:Valerates; D014667:Vasopressins; D000804:Angiotensin II; D000249:Adenosine Monophosphate; D009638:Norepinephrine